Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Cancer discovery
2021
IFITM3 Enhances PI3K Pathway Signaling to Promote B-cell Malignancies.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
1 paper cites it
2021
2022
2023
this paper
cites it
IFITM3 Enhances PI3K Pathway Signaling to Promote B-cell Malignancies. | OpenQuestion